Noninvasive Magnetic Resonance Imaging Detection of Cerebral Amyloid Angiopathy-Related Microvascular Alterations Using Superparamagnetic Iron Oxide Particles in APP Transgenic Mouse Models of Alzheimer's Disease: Application to Passive Aβ Immunotherapy
Authors:
- Nicolau BeckmannNBNicolau Beckmann
- Christelle GérardCGChristelle Gérard
- Dorothée AbramowskiDADorothée Abramowski
- Catherine CannetCCCatherine Cannet
- Matthias StaufenbielMSMatthias Staufenbiel
Open Access
- 19 January 2011
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 31 (3) , 1023-1031
Abstract
Cerebral amyloid angiopathy (CAA) is a common feature of Alzheimer's disease (AD). More advanced stages are accompanied by microhemorrhages and vasculitis. Peripheral blood-borne macrophages are intimately linked to cerebrovascular pathology coincident with AD. Magnetic resonance imaging (MRI) was used to noninvasively study microvascular lesions in amyloid precursor protein transgenic mouse AD models. Foci of signal attenuation were detected in cortical and thalamic brain regions of aged APP23 mice. Their strength and number was considerably enhanced by intravenous administration of iron oxide nanoparticles, which are taken up by macrophages through absorptive endocytosis, 24 h before image acquisition. The number of cortical sites displaying signal attenuation increased with age. Histology at these sites demonstrated the presence of iron-containing macrophages in the vicinity of CAA-affected blood vessels. A fraction of the sites additionally showed thickened vessel walls and vasculitis. Consistent with the visualization of CAA-associated lesions, MRI detected a much smaller number of attenuated signal sites in APP23xPS45 mice, for which a strong presenilin mutation caused a shift toward amyloid β42, thus reducing vascular amyloid. Similar results were obtained with APP24 and APP51 mice, which develop significantly less CAA and microvascular pathology than APP23. In a longitudinal study, we noninvasively demonstrated the reinforced formation of microvascular pathology during passive amyloid β immunotherapy of APP23 mice. Histology confirmed that foci of signal attenuation reflected an increase in CAA-related lesions. Our data demonstrate that MRI has the sensitivity to noninvasively monitor the development of vascular pathology and its possible enhancement by amyloid β immunotherapy in transgenic mice modeling AD.Keywords
This publication has 37 references indexed in Scilit:
- Imaging cerebral microbleeds using susceptibility weighted imaging: One step toward detecting vascular dementiaJournal of Magnetic Resonance Imaging, 2009
- Consequence of Aβ immunization on the vasculature of human Alzheimer's disease brainBrain, 2008
- Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer's DiseaseScience, 2008
- Active and Passive Immunotherapy for Neurodegenerative DisordersAnnual Review of Neuroscience, 2008
- Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's diseaseProceedings of the National Academy of Sciences, 2008
- Vessel ultrastructure in APP23 transgenic mice after passive anti-Aβ immunotherapy and subsequent intracerebral hemorrhageNeurobiology of Aging, 2007
- Amyloid-β vaccination, but not nitro-nonsteroidal anti-inflammatory drug treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloidNeuroscience, 2007
- Cerebral Hemorrhage After Passive Anti-Aβ ImmunotherapyScience, 2002
- Alzheimer disease and cerebrovascular pathology: an updateJournal of Neural Transmission, 2002
- Small Chronic Hemorrhages and Ischemic Lesions in Association With Spontaneous Intracerebral HematomasStroke, 1999